Because the antibiotic pipeline threatens to run dry, the role of academic centers and scientific institutions supported by government funds in developing new anti-infection technologies is becoming increasingly crucial. Among the methods alternative to antibiotics and chemotherapeutics for combating bacterial infections, therapy using bacteriophages is frequently mentioned